The Weekly Roundup: October 10-14


ICYMI, this week we had stories about the American Society for Dermatologic Surgery Meeting, pediatric nail disorders, generalized pustular psoriasis treatment, and more.

Tina Alster, MD, Receives Vic Narurkar Aesthetic Lectureship in Aesthetic Innovations

The legacy of the late Vic Narurkar, MD, and his commitment to aesthetics was honored at the 2022 Annual ASDS Meeting.

A Study of Immune Checkpoint Inhibitors & Complication Rates

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

Clinical Pearls for Superficial and Medium Depth Chemical Peels

Harold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.

The Switch to Regenerative Medicine

Saranya Wyles, MD, PhD, takes a closer look at skin aging, cellular senescence, and emerging regenerative medicine techniques at the 2022 Annual ASDS Meeting.

Embracing Value-Based Care

Six strategies for profitability with new payment models.

Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 Years

A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.

Phase 3 Trial Shows Intravenous Immune Globulin Effective for Dermatomyositis

Patients saw improvements in the first-ever phase 3 trial of the blood therapy for the condition.

The Psychosocial Impact of Skin Diseases in Children

Acne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families.

Switching Therapies in Psoriasis

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide insight on when it is appropriate to switch from one biologic to another for a patient with psoriasis.

Biosimilars in Psoriasis

Drs Mark G. Lebwohl and Joseph F. Merola discuss the use of biosimilars in psoriasis and how biosimilars will change the treatment landscape.

Pointers With Dr Portela: Holistic vs. Western Medicine for Eczema

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses holistic medicine vs. western medicine for eczema treatment.

Recap of the American Society for Dermatologic Surgery Meeting

Catch up on coverage from the editors of Dermatology Times® who attended the annual ASDS Meeting.

No Greater COVID-19 Risk for Atopic Dermatitis Patients Treated with Tralokinumab

A new study shows the AD drug does not interfere with vaccinations or increase severity.

Vitiligo Repigmentation Improvements More Noticeable in Patient-Reported Outcome Measures

Improvement of vitiligo repigmentation in patients can result in higher Vitiligo Noticeability Scale values when assessed from patient-reported outcome measures (PROMs) versus traditional investigator-assessed studies.

Innovation Leads to “Windfall” in Dermatology

Continued research and development are resulting in exciting new treatment options for major dermatological conditions.

Physicians Don’t Have to be Mental Health Experts to Become Mental Well-Being Advocates

Lack of providers, stigma are barriers to seeking needed care, but meaningful conversations can help.

Pediatric Nail Disorders

Management differs from adults and requires a meticulous examination to rule out underlying diseases.

Study Suggests Significant Unmet Need in Current GPP Treatment

Patients with generalized pustular psoriasis flares were 2 times more likely to have emergency department visits.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.